Some SCLC subtypes rarely showed ASCL1 or NeuroD1 mutations but rather expressed others, including those derived from the coding of YAP1 and POU2F3, which are related to the loss of neuroendocrine characteristics of the tumor. The gene discussed is YAP1; the disease is neoplasm.